The pharmaceutical industry's prolonged and painful period of restructuring looks set to continue, and UK pharma is thought to be the worst hit in Europe.
One leading recruitment boss says he has never seen such heavy cutbacks in the industry, with the current climate far worse than the downsizing seen in the early nineties.
Nick Stephens is chief executive of RSA, a recruitment company with offices in the UK, France, Switzerland and China. He says the UK's long-term outlook is bleak for jobs in sales, R&D, production, or anything else that can be outsourced.
And unlike during any other period of pharma job losses, he says the cuts have been coming "fast and deep".
In total it is estimated that the UK industry has cut 11-15% of jobs across all divisions over the last two years.
More
1 comment:
Nick Stephens is right, but with the remark that Primary Care product lines are suffering much more than specialized, hospital and niche-focused lines.
Companies with productive R&D pipelines still need talent in the UK and in the rest of the Europe.
Post a Comment